Age-related macular degeneration: An emerging challenge for eye care and public health professionals in the Asia Pacific region

Annals of the Academy of Medicine Singapore

Volumn 35, Issue 3, 2006, Pages 133-135

  Eong, Kah Guan Au ^a,b,c,d  

^a ALEXANDRA HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^d TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CHOLESTEROL; ENDOTHELIAL CELL GROWTH FACTOR; FIBRINOGEN; ZINC;

ASIA; CATARACT; CATARACT EXTRACTION; CHOLESTEROL BLOOD LEVEL; COST BENEFIT ANALYSIS; DIABETIC RETINOPATHY; EDITORIAL; EYE CARE; GLAUCOMA; HEALTH PRACTITIONER; HUMAN; HYPERTENSION; INTRAOCULAR HEMORRHAGE; LASER COAGULATION; OBESITY; PHOTODYNAMIC THERAPY; PUBLIC HEALTH SERVICE; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SCAR FORMATION; SUBRETINAL NEOVASCULARIZATION; VASCULAR DISEASE; VISUAL ACUITY;

EID: 33745195463     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Editorial

References (26)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844-51.
2. Taylor HR. Eye care for the future: the Weisenfeld lecture. Invest Ophthalmol Vis Sci 2003;44:1413-8.
3. Valbuena M, Bandeen-Roche K, Rubin GS, Munoz B, West SK. Self-reported assessment of visual function in a population-based study: the SEE project. Salisbury Eye Evaluation. Invest Ophthalmol Vis Sci 1999;40:280-8.
4. Crews JE, Campbell VA. Vision impairment and hearing loss among community-dwelling older Americans: implications for health and functioning. Am J Public Health 2004;94:823-9.
5. Legood R, Scuffham P, Cryer C. Are we blind to injuries in the visually impaired? A review of the literature. Inj Prev 2002;8:155-60.
6. Ivers RQ, Cumming RG, Mitchell P, Attebo K. Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc 1998;46:58-64.
7. Rovner BW, Ganguli M. Depression and disability associated with impaired vision: the MoVIES project. J Am Geriatr Soc 1998;46:617-9.
8. Rizzo M, Kellison IL. Eyes, brains, and autos. Arch Ophthalmol 2004;122:641-7.
9. McCarty CA, Nanjan MB, Taylor HR. Vision impairment predicts 5 year mortality. Br J Ophthalmol 2001;85:322-6.
10. Wang JJ, Mitchell P, Simpson JM, Cumming RG, Smith W. Visual impairment, age-related cataract, and mortality. Arch Ophthalmol 2001;119:1186-90.
11. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 1999;117:1487-95.
12. Bonastre J, Le Pen C, Soubrane G, Quentel G. The burden of age-related macular degeneration: results of a cohort study in two French referral centres. Pharmacoeconomics 2003;21:181-90.
13. Bonastre J, Le Pen C, Anderson P, Ganz A, Berto P, Berdeaux G. The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom. Eur J Health Econ 2002;3:94-102.
14. Centre for Eye Research Australia. Centrally focussed. The impact of age-related macular degeneration. Melbourne: Centre for Eye Research Australia, 2006.
15. Bylsma GW, Guymer RH. Treatment of age-related macular degeneration. Clin Exp Optom 2005;88:322-34.
16. Constable IJ. Age-related macular degeneration and its possible prevention. Med J Aust 2004;181:471-2.
17. Cohen MM. Age-related macular degeneration and its possible prevention. Med J Aust 2005;182:310-1.
18. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye 2005;19:935-44.
19. Au Eong KG, Haller JA. Risk factors of age-related macular degeneration and choroidal neovascularization. In: Lim JI, editor. Age-related Macular Degeneration. New York: Marcel Dekker, 2002:chap. 20.
20. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-36.
21. Klein R, Klein BEK, Cruickshanks KJ. The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 1999;18:371-89.
22. Hawkins BS, Bird AC, Klein R, West SK. Epidemiology of age-related macular degeneration. Mol Vis 1999;5:26.
23. Ciardella AP, Donsoff IM, Huang SJ, Costa DL, Yannuzzi LA. Polypoidal choroidal vasculopathy. Surv Ophthalmol 2004;49:25-37.
24. Kwok AK, Lai TY, Chan CW, Neoh EL, Lam DS. Polypoidal choroidal vasculopathy in Chinese patients. Br J Ophthalmol 2002;86:892-7.
25. Lau JT, Lee V, Fan D, Lau M, Michon J. Knowledge about cataract, glaucoma and age related macular degeneration in the Hong Kong Chinese population. Br J Ophthalmol 2002;86:1080-4.
26. AMD Alliance International. Awareness of age-related macular degeneration and associated risk factors: AMD Global Report 2005. Toronto: AMD Alliance International, 2005.